Immucell (ICCC) Cash & Equivalents Growth (1y) (2011 - 2026)
Powered by 
Analysis
Immucell (ICCC) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 19.65% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 2.86% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -1.67% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -9.73% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 47.71% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 174.00% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 23.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.71% |
| Dec 31, 2025 | 1.29% |
| Sep 30, 2025 | 2.04% |
| Jun 30, 2025 | 352.96% |
| Mar 31, 2025 | 378.93% |
| Dec 31, 2024 | 283.99% |
| Sep 30, 2024 | 91.44% |
| Jun 30, 2024 | -8.94% |
| Mar 31, 2024 | -68.98% |
| Dec 31, 2023 | -83.10% |
| Sep 30, 2023 | -77.46% |
| Jun 30, 2023 | -86.83% |
| Mar 31, 2023 | -73.80% |
| Dec 31, 2022 | -43.14% |
| Sep 30, 2022 | -15.89% |
| Jun 30, 2022 | 3.20% |
| Mar 31, 2022 | 73.61% |
| Dec 31, 2021 | 46.55% |
| Sep 30, 2021 | 77.57% |
| Jun 30, 2021 | 30.58% |